Vascepa is a prescription medication that contains the active ingredient icosapent ethyl, which is used to reduce the risk of cardiovascular events such as heart attack and stroke in patients with high triglyceride levels [1]. According to the manufacturer's website, Vascepa is intended for long-term use, and the duration of treatment should be determined by a healthcare provider based on individual patient needs [3].

While the exact length of time a patient may need to take Vascepa can vary, a study published in the New England Journal of Medicine found that treatment with icosapent ethyl for approximately five years significantly reduced the risk of cardiovascular events in patients with elevated triglyceride levels [2]. Additionally, a review of clinical trials conducted on Vascepa found that the medication demonstrated consistent cardiovascular risk reduction over a median treatment period of 4.9 years [1].

It is important to note that Vascepa is not a cure for high triglyceride levels or cardiovascular disease, and patients should continue to take the medication as directed by their healthcare provider to maintain its benefits [3]. Patients should also be aware of the potential side effects of Vascepa, which may include joint pain, swelling, and gastrointestinal symptoms [3].

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.nejm.org/doi/full/10.1056/NEJMoa1812792
[3] https://www.vascepa.com/